查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1692288

無針糖尿病護理市場 - 全球行業規模、佔有率、趨勢、機會和預測，按設備類型、按最終用戶、按地區和競爭細分，2020-2030 年預測

Needle Free Diabetes Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device Type, By End User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球無針糖尿病護理市場價值為 135.1 億美元，預計在預測期內將經歷顯著成長，到 2030 年預計年複合成長率(CAGR) 為 5.90%。該市場專注於為糖尿病管理提供傳統胰島素注射方法的替代方案，為糖尿病患者提供更方便、更少痛苦的選擇。

市場概況
預測期 2026-2030
2024 年市場規模 135.1 億美元
2030 年市場規模 189億美元
2025-2030 年複合年成長率 5.90％
成長最快的領域 胰島素幫浦
最大的市場 北美洲

主要市場促進因素：

糖尿病盛行率上升

主要市場挑戰：

監管部門批准

主要市場趨勢：

閉迴路系統

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球無針糖尿病治療市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依設備類型（胰島素輸注器、胰島素貼片、胰島素筆、胰島素幫浦、噴射器）
    • 按最終使用者（家庭護理、診斷中心、醫院和診所）
    • 按地區
    • 按公司分類（2024）
  • 產品市場圖
    • 依設備類型
    • 按最終用戶
    • 按地區

第 6 章：北美無針糖尿病治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第 7 章：歐洲無針糖尿病護理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 法國
    • 義大利
    • 西班牙

第 8 章：亞太無針糖尿病治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 日本
    • 印度
    • 澳洲
    • 韓國

第 9 章：南美洲無針糖尿病護理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲無針糖尿病護理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 合併與收購
  • 產品發布

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • 3M Co
  • Bioject Medical Technologies Inc
  • Valeritas Inc
  • Antares Pharma Inc
  • Endo International PLC
  • InsuJet
  • Pharmajet Inc
  • INJEX Pharma AG
  • Johnson & Johnson
  • MannKind Corp

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 18811

The global Needle-Free Diabetes Care market was valued at USD 13.51 billion in 2024 and is expected to experience significant growth during the forecast period, with a projected compound annual growth rate (CAGR) of 5.90% through 2030. This market focuses on providing alternatives to traditional insulin injection methods for the management of diabetes, offering more convenient and less painful options for individuals with diabetes.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 13.51 Billion
Market Size 2030USD 18.90 Billion
CAGR 2025-20305.90%
Fastest Growing SegmentInsulin Pumps
Largest MarketNorth America

Key Market Drivers:

Rising Prevalence of Diabetes

The increasing prevalence of diabetes is largely driven by factors such as sedentary lifestyles, poor dietary habits, and an aging population. This growing global health concern not only impacts individual health but also places a substantial strain on healthcare systems and economies. According to the World Health Organization (WHO), diabetes is a chronic condition characterized by elevated blood glucose levels, which can lead to severe complications. Over 830 million people worldwide are affected by diabetes, with a significant proportion living in low- and middle-income countries. Diabetes management is shifting from a physician-centered model to a more patient-centric approach. Patients now seek solutions that offer greater convenience, reduce pain, and improve their quality of life. As traditional insulin injections are often seen as uncomfortable and inconvenient, there is an increasing demand for needle-free alternatives.

Key Market Challenges:

Regulatory Approvals

One of the key challenges in the needle-free diabetes care market is the need for regulatory approvals for new devices and technologies. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict safety and efficacy standards, making the approval process time-consuming and costly for manufacturers. These regulatory hurdles can delay the introduction of new products into the market.

Key Market Trends:

Closed-Loop Systems

Closed-loop insulin delivery systems, often referred to as artificial pancreases, are gaining popularity in the diabetes care market. These systems automatically adjust insulin delivery based on continuous glucose monitoring (CGM) data, providing users with better control over their blood glucose levels. As technology continues to evolve, closed-loop systems are expected to become more accessible, user-friendly, and effective.

Key Market Players:

  • 3M Co
  • Bioject Medical Technologies Inc
  • Valeritas Inc
  • Antares Pharma Inc
  • Endo International PLC
  • InsuJet
  • PharmaJet Inc
  • INJEX Pharma AG
  • Johnson & Johnson
  • MannKind Corp

Report Scope:

This report segments the global Needle-Free Diabetes Care market into the following categories, while also providing insights into key industry trends:

By Device Type:

  • Insulin Infusers
  • Insulin Patches
  • Insulin Pens
  • Insulin Pumps
  • Jet Injectors

By End-User:

  • Homecare
  • Diagnostic Centers
  • Hospitals & Clinics

By Region:

  • North America: United States, Canada, Mexico
  • Europe: Germany, United Kingdom, France, Italy, Spain
  • Asia-Pacific: China, Japan, India, Australia, South Korea
  • South America: Brazil, Argentina, Colombia
  • Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait

Competitive Landscape and Company Profiles:

This section provides an in-depth analysis of the major players operating in the global Needle-Free Diabetes Care market.

Available Customizations:

TechSci Research offers customized reports based on specific market data for the global Needle-Free Diabetes Care market. The following customization options are available:

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Needle Free Diabetes Care Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
    • 5.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Device Type
    • 5.3.2. By End User
    • 5.3.3. By Region

6. North America Needle Free Diabetes Care Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
    • 6.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Needle Free Diabetes Care Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Needle Free Diabetes Care Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Needle Free Diabetes Care Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device Type
        • 6.3.3.2.2. By End User

7. Europe Needle Free Diabetes Care Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
    • 7.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Needle Free Diabetes Care Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device Type
        • 7.3.1.2.2. By End User
    • 7.3.2. United Kingdom Needle Free Diabetes Care Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device Type
        • 7.3.2.2.2. By End User
    • 7.3.3. France Needle Free Diabetes Care Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Needle Free Diabetes Care Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Needle Free Diabetes Care Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Needle Free Diabetes Care Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
    • 8.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Needle Free Diabetes Care Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device Type
        • 8.3.1.2.2. By End User
    • 8.3.2. Japan Needle Free Diabetes Care Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device Type
        • 8.3.2.2.2. By End User
    • 8.3.3. India Needle Free Diabetes Care Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device Type
        • 8.3.3.2.2. By End User
    • 8.3.4. Australia Needle Free Diabetes Care Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device Type
        • 8.3.4.2.2. By End User
    • 8.3.5. South Korea Needle Free Diabetes Care Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device Type
        • 8.3.5.2.2. By End User

9. South America Needle Free Diabetes Care Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
    • 9.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Needle Free Diabetes Care Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Needle Free Diabetes Care Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Needle Free Diabetes Care Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Needle Free Diabetes Care Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
    • 10.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Needle Free Diabetes Care Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Needle Free Diabetes Care Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Needle Free Diabetes Care Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device Type
        • 10.3.3.2.2. By End User
    • 10.3.4. Kuwait Needle Free Diabetes Care Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Device Type
        • 10.3.4.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. 3M Co
  • 14.2. Bioject Medical Technologies Inc
  • 14.3. Valeritas Inc
  • 14.4. Antares Pharma Inc
  • 14.5. Endo International PLC
  • 14.6. InsuJet
  • 14.7. Pharmajet Inc
  • 14.8. INJEX Pharma AG
  • 14.9. Johnson & Johnson
  • 14.10.MannKind Corp

15. Strategic Recommendations

16. About Us & Disclaimer